NUV-3849643-9/20002/1

Novartis Pharmaceuticals Corporation — FEI 3010353512

Refusal Details

Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58MCP25 SECUKINUMAB
Charges
179